Market revenue in 2023 | USD 268.4 million |
Market revenue in 2030 | USD 1,410.6 million |
Growth rate | 26.7% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 49.48% in 2023. Horizon Databook has segmented the India dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
India is anticipated to be a high-potential market for NGS in Asia Pacific, owing to the presence of a large target population. Continuous government support and funding have enhanced the scope of NGS in the country.
In April 2019, the Council of Scientific and Industrial Research (CSIR) initiated the IndiGen program. This initiative aimed to take whole-genome sequencing of numerous people representing distinct ethnic groups.
In addition, the well established agriculture sector in the country and continuous initiatives by regional players in agri genomics field are expected to support the market. In April 2018, 3B Black Bio Biotech India, a subsidiary of Kilpest India Ltd., acquired Thermo Fisher Scientific’s NGS system, Ion Gene Studio S5 System, to enter into clinical genetics.
Horizon Databook provides a detailed overview of country-level data and insights on the India dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into India dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account